focus
WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.
Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.
advertisement
But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.
Get unlimited access to award-winning journalism and exclusive events.
Subscribe Log In
Previous article：
The White House hikes tariffs on plastic syringes made in China
Next article： Drug repurposing or repositioning? The language matters
Next article： Drug repurposing or repositioning? The language matters
